IMMURON LIMITED

0.00%

6.8¢

Market Cap $18.23M

Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Latest Threads

Tag

Subject

IMC

Ann: FY25 Results Presentation

29/08/25

538

29/08/25

Last post davide1

538

IMC

Ann: Appendix 4E Preliminary Final Report

29/08/25

107

29/08/25

Last post

ASX News

107

IMC

New website

27/08/25

369

27/08/25

Last post davide1

369

IMC

Ann: Immuron partners with InvestorHub

26/08/25

170

26/08/25

Last post

ASX News

170

IMC

Ann: Notification regarding unquoted securities - IMC

15/08/25

254

15/08/25

Last post

ASX News

254

IMC

Ann: Emerging Growth Conference Presentation

14/08/25

1.0K

14/08/25

Last post davide1

1.0K

IMC

Ann: Presentation to Coffee Microcaps Conference

31/07/25

3.8K

31/07/25

Last post ich

3.8K

IMC

Ann: FY25 global sales exceed projection, up 49% on prior year

25/07/25

7.3K

25/07/25

Last post shail151

7.3K

See All Discussions

Timeline

FY25 Results Presentation
29 Aug 09:36	Share

Appendix 4E Preliminary Final Report
29 Aug 09:35	Share

Immuron partners with InvestorHub
26 Aug 12:10	Share

Notification regarding unquoted securities - IMC
15 Aug 09:11	Share

Emerging Growth Conference Presentation
13 Aug 09:22	Share

Presentation to Coffee Microcaps Conference
25 Jul 09:42	Share

Change in substantial holding
23 Jul 08:16	Share

Notification of cessation of securities - IMC
22 Jul 09:27	Share

Notice under section 708A
21 Jul 08:23	Share

Application for quotation of securities - IMC
21 Jul 08:22	Share

Proposed issue of securities - IMC
18 Jul 12:08	Share

Notice under section 708A
18 Jul 08:20	Share

Application for quotation of securities - IMC
18 Jul 08:20	Share

Proposed issue of securities - IMC
17 Jul 10:32	Share

Notice under section 708A
17 Jul 09:56	Share

Application for quotation of securities - IMC
17 Jul 09:44	Share

FY25 global sales exceed projection, up 49% on prior year
17 Jul 08:44	Share

Proposed issue of securities - IMC
16 Jul 12:59	Share

Change in substantial holding
01 Jul 08:27	Share

Notice under section 708A
04 Jun 08:32	Share

Application for quotation of securities - IMC
04 Jun 08:27	Share

Proposed issue of securities - IMC
03 Jun 16:39	Share

Letter to Shareholders
30 May 09:33	Share

Notice under section 708A
30 May 09:06	Share

Application for quotation of securities - IMC
30 May 09:01	Share

Proposed issue of securities - IMC
29 May 16:29	Share

Notice under section 708A
11 Apr 14:59	Share

Notification of cessation of securities - IMC
11 Apr 14:57	Share

Application for quotation of securities - IMC
11 Apr 14:56	Share

Immuron Travelan highest sales in history
10 Apr 11:20	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.8¢		Change 0.000(0.00%)		Mkt cap ! $18.23M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	254876	6.8¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	20743	2

View Market Depth

No.	Vol.	Price($)
2	254876	0.068
2	10000	0.067
1	75000	0.066
3	87126	0.065
1	15858	0.063

Price($)	Vol.	No.
0.072	20743	2
0.073	22750	2
0.075	23346	2
0.076	15546	1
0.079	112658	2

Last trade - 16.21pm 05/09/2025 (20 minute delay)

IMC (ASX) Chart

Day chart unavailable

IMMURON LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Immuron progresses development of traveller's diarrhea drug Travelan

Immuron Ltd has presented a Clinical Study Report to the US Food and Drug Administration following its Phase 2 clinical trial

Immuron (ASX:IMC) sees global sales boost of 136pc in FY23

Immuron (ASX:IMC) has announced that its FY23 global sales have increased by 136 per cent on FY22 sales.

Immuron (ASX:IMC) reports boost in Q3 sales of Travelan and Protectyn

Shares in Melbourne-based biotech company Immuron (ASX:IMC) were soaring on Thursday after posting its Q3 FY23 financial figures.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News